These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31148382)

  • 1. Regional practice norms for the care of childhood cancer survivors at risk for cardiomyopathy: A Delphi study.
    Kenney LB; Ames B; Margossian R; Moss K; Michaud AL; Williams DN; Nohria A
    Pediatr Blood Cancer; 2019 Sep; 66(9):e27868. PubMed ID: 31148382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The management of childhood cancer survivors at risk for stroke: A Delphi survey of regional experts.
    Kenney LB; Ames B; Michaud AL; Williams DN; Manley PE; Ullrich NJ
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27394. PubMed ID: 30094926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delphi Panel Consensus Recommendations for Screening and Managing Childhood Cancer Survivors at Risk for Cardiomyopathy.
    Aziz-Bose R; Margossian R; Ames BL; Moss K; Ehrhardt MJ; Armenian SH; Yock TI; Nekhlyudov L; Williams D; Hudson M; Nohria A; Kenney LB
    JACC CardioOncol; 2022 Sep; 4(3):354-367. PubMed ID: 36213355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consensus Recommendations for Managing Childhood Cancer Survivors at Risk for Stroke After Cranial Irradiation: A Delphi Study.
    Kenney LB; Ames BL; Huang MS; Yock T; Bowers DC; Nekhlyudov L; Williams D; Hudson MM; Ullrich NJ
    Neurology; 2022 Oct; 99(16):e1755-e1766. PubMed ID: 35977833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of childhood cancer survivors at risk for thyroid function abnormalities: A Delphi study.
    Welch JJG; Ames B; Cohen LE; Gaufberg E; Hudson MM; Nathan PC; Nekhlyudov L; Yock TI; Chemaitilly W; Kenney LB
    Pediatr Blood Cancer; 2022 Dec; 69(12):e29942. PubMed ID: 36069601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anthracycline-induced cardiomyopathy].
    Roul G; Cohen C; Lieber A
    Presse Med; 2009 Jun; 38(6):987-94. PubMed ID: 19423276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of the children's oncology group long-term follow-up screening guidelines for childhood cancer survivors at risk for treatment-related heart failure.
    Wong FL; Bhatia S; Landier W; Francisco L; Leisenring W; Hudson MM; Armstrong GT; Mertens A; Stovall M; Robison LL; Lyman GH; Lipshultz SE; Armenian SH
    Ann Intern Med; 2014 May; 160(10):672-83. PubMed ID: 24842414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac function in childhood cancer survivors treated with vincristine: Echocardiographic results from the DCCSS LATER 2 CARD study.
    Merkx R; Feijen ELAM; Leerink JM; de Baat EC; Bellersen L; van Dalen EC; van Dulmen-den Broeder E; van der Heiden-van der Loo M; van den Heuvel-Eibrink MM; de Korte CL; Loonen J; Louwerens M; Ronckers CM; Teske AJ; Tissing WJE; de Vries ACH; Mavinkurve-Groothuis AMC; van der Pal HJH; Weijers G; Kok WEM; Kremer LCM; Kapusta L;
    Int J Cardiol; 2022 Dec; 369():69-76. PubMed ID: 35926643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subclinical anthracycline-induced cardiotoxicity in long-term follow-up of asymptomatic childhood cancer survivors: Assessment by speckle tracking echocardiography.
    Çetin S; Babaoğlu K; Başar EZ; Deveci M; Çorapçıoğlu F
    Echocardiography; 2018 Feb; 35(2):234-240. PubMed ID: 29106752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic Myocardial Response to Exercise in Childhood Cancer Survivors Treated with Anthracyclines.
    Cifra B; Chen CK; Fan CS; Slorach C; Manlhiot C; McCrindle BW; Dragulescu A; Redington AN; Friedberg MK; Nathan PC; Mertens L
    J Am Soc Echocardiogr; 2018 Aug; 31(8):933-942. PubMed ID: 29615292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth-differentiation factor-15 and tissue doppler ımaging in detection of asymptomatic anthracycline cardiomyopathy in childhood cancer survivors.
    Arslan D; Cihan T; Kose D; Vatansev H; Cimen D; Koksal Y; Oran B; Akyurek F
    Clin Biochem; 2013 Sep; 46(13-14):1239-43. PubMed ID: 23850849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation and management of chemotherapy-induced cardiotoxicity in breast cancer: a Delphi study.
    Gavila J; Seguí MÁ; Calvo L; López T; Alonso JJ; Farto M; Sánchez-de la Rosa R
    Clin Transl Oncol; 2017 Jan; 19(1):91-104. PubMed ID: 27101413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioprotective role of β-blockers and angiotensin antagonists in early-onset anthracyclines-induced cardiotoxicity in adult patients: a systematic review and meta-analysis.
    Yun S; Vincelette ND; Abraham I
    Postgrad Med J; 2015 Nov; 91(1081):627-33. PubMed ID: 26399268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anthracycline-related cardiotoxicity in childhood cancer survivors.
    Lipshultz SE; Karnik R; Sambatakos P; Franco VI; Ross SW; Miller TL
    Curr Opin Cardiol; 2014 Jan; 29(1):103-12. PubMed ID: 24284979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of Echocardiography as Screening for Late-onset Anthracycline-induced Cardiotoxicity in Pediatric Cancer Survivors: Observations from the First Decade After End of Therapy.
    Moke DJ; Schubert LE; Sun HY; Printz BF; Dietz AC
    J Pediatr Hematol Oncol; 2018 Jul; 40(5):e283-e288. PubMed ID: 29432303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personalized Approach to Cancer Treatment-Related Cardiomyopathy.
    Slivnick J; Vallakati A; Addison D; Wallner A; Tong MS
    Curr Heart Fail Rep; 2020 Apr; 17(2):43-55. PubMed ID: 32125627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anthracycline-Induced Cardiotoxicity in Young Cancer Patients: The Role of Carnitine.
    Armenian SH
    Ann Nutr Metab; 2016; 68 Suppl 3():10-14. PubMed ID: 27931027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anthracycline-induced cardiotoxicity in children with cancer: strategies for prevention and management.
    Iarussi D; Indolfi P; Casale F; Martino V; Di Tullio MT; Calabrò R
    Paediatr Drugs; 2005; 7(2):67-76. PubMed ID: 15871628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Enalapril on Preventing Anthracycline-Induced Cardiomyopathy.
    Janbabai G; Nabati M; Faghihinia M; Azizi S; Borhani S; Yazdani J
    Cardiovasc Toxicol; 2017 Apr; 17(2):130-139. PubMed ID: 27003392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yield of screening echocardiograms during pediatric follow-up in survivors treated with anthracyclines and cardiotoxic radiation.
    Spewak MB; Williamson RS; Mertens AC; Border WL; Meacham LR; Wasilewski-Masker KJ
    Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 27966803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.